Disparate SARS-CoV-2 Infection Outcomes Abound, but What Makes SARS-CoV-2 Bound for Rebound?

被引：1
|
作者：
Sheahan, Timothy P. [1 ,2 ,3 ]
机构：
[1] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, 3113 MHRC,135 Dauer Dr,Campus Box 7435, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Rapidly Emerging Antiviral Drug Dev Initiat, Chapel Hill, NC 27599 USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2024年
关键词：
CORONAVIRUS;
D O I：
10.1093/infdis/jiae386
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Evaluation of the EasyNAT SARS-CoV-2 assay PCR test for the diagnosis of SARS-CoV-2 infection
    Fernandez-Sanchez, Fernando
    Martin-Bautista, Elena
    Rivas-Ruiz, Francisco
    Wu, Winnie
    Garcia-Aranda, Marilina
    JOURNAL OF VIROLOGICAL METHODS, 2024, 326
  • [42] SARS-CoV-2 antigen rapid tests For reliable detection of SARS-CoV-2 infection not suitable
    Reuter, Tom
    Lange, Constanze
    Zeyher, Sharay
    Woelk, Benno
    Kramer, Jan
    PRAVENTION UND GESUNDHEITSFORDERUNG, 2023, 18 (03): : 370 - 376
  • [43] SARS-CoV-2 infection and cancer Evidence for and against a role of SARS-CoV-2 in cancer onset
    Stingi, Aureliano
    Cirillo, Luca
    BIOESSAYS, 2021, 43 (08)
  • [44] Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
    Moran, Angelica
    Beavis, Kathleen G.
    Matushek, Scott M.
    Ciaglia, Carol
    Francois, Nina
    Tesic, Vera
    Love, Nedra
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (08)
  • [45] What makes SARS-CoV-2 unique? Focusing on the spike protein
    Qian, Jingbo
    Zhang, Shichang
    Wang, Fang
    Li, Jinming
    Zhang, Jiexin
    CELL BIOLOGY INTERNATIONAL, 2024, 48 (04) : 404 - 430
  • [46] What should define a SARS-CoV-2 "breakthrough" infection?
    Schieffelin, John S.
    Norton, Elizabeth B.
    Kolls, Jay K.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (12):
  • [47] Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known?
    Rodrigues, Patricia Brito
    Dos Santos Pereira Gomes, Arilson Bernardo
    Genaro, Livia Moreira
    Pascoal, Livia Bitencourt
    Duarte De Souza, Ana Paula
    Leal, Raquel Franco
    Ramirez Vinolo, Marco Aurelio
    IDENTIFCATION OF BIOMARKERS, NEW TREATMENTS, AND VACCINES FOR COVID-19, 2021, 1327 : 93 - 106
  • [48] Methotrexate/methylprednisolone/prednisoneProlonged SARS-CoV-2 infection and masking of the symptoms of SARS-CoV-2 infection: case report
    Reactions Weekly, 2020, 1826 (1) : 209 - 209
  • [49] Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
    Drosos, Alexandros A.
    Pelechas, Eleftherios
    Drossou, Vassiliki
    Voulgari, Paraskevi V.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 379 - 389
  • [50] Colchicine Against SARS-CoV-2 Infection: What is the Evidence?
    Alexandros A. Drosos
    Eleftherios Pelechas
    Vassiliki Drossou
    Paraskevi V. Voulgari
    Rheumatology and Therapy, 2022, 9 : 379 - 389
12345